Effect of chronic intermittent hypoxia on apoptosis based on microbiome-based co-metabolomics
- Exp Neurol. 2026 Jul:401:115726. doi: 10.1016/j.expneurol.2026.115726.
- 1. Guizhou University Medical College, Guiyang 550025, Guizhou Province, China.
- 2. Zunyi Medical University, 563000, Guizhou Province, China.
- 3. Guizhou University of Traditional Chinese Medicine, 550002, Guizhou Province, China.
- 4. Department of Sleep Medicine, Guizhou Provincial People's Hospital, 550002, Guizhou Province,China.
- 5. Department of Sleep Medicine, Guizhou Provincial People's Hospital, 550002, Guizhou Province,China. Electronic address: [email protected].
Background: Obstructive sleep apnea (OSA) is linked to metabolic dysfunction, but the role of chronic intermittent hypoxia (CIH)-induced mitochondrial Apoptosis remains unclear. This study investigated whether CIH-induced lung Apoptosis involves gut microbiota and metabolite changes.
Methods: Mice exposed to CIH were analyzed using 16S rRNA Sequencing and GC-MS metabolomics. Apoptosis markers (Drp1, Bax, Bcl-2, Caspase-3) were assessed via Western blot, immunohistochemistry, TUNEL, and electron microscopy.
Results: (1) CIH disrupted fatty acid metabolism (e.g., decreased arachidonic acid, increased nervonic acid), reversible with Mdivi-1 (mitochondrial fission inhibitor). (2) CIH altered gut microbiota, partially restored by Mdivi-1. (3) KEGG analysis revealed Apoptosis, Autophagy, and P53 pathway changes. (4) CIH reduced mouse weight and cognitive performance; Mdivi-1 improved these. (5) CIH increased Bax/Caspase-3 and decreased Bcl-2, worsening mitochondrial damage-exacerbated by CCCP (Apoptosis Inducer) but mitigated by Mdivi-1.
Conclusions: Mdivi-1 alleviated CIH-induced gut dysbiosis, Apoptosis, and mitochondrial damage, while CCCP worsened these effects. Gut microbiota and metabolic changes may mediate CIH-induced lung Apoptosis.
-
Cat. No.Product NameDescriptionTargetResearch Area